KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Non-Current Deferred Tax Liability (2016 - 2018)

Historic Non-Current Deferred Tax Liability for Vertex Pharmaceuticals (VRTX) over the last 10 years, with Q3 2018 value amounting to $9.4 million.

  • Vertex Pharmaceuticals' Non-Current Deferred Tax Liability fell 1187.04% to $9.4 million in Q3 2018 from the same period last year, while for Sep 2018 it was $9.4 million, marking a year-over-year decrease of 1187.04%. This contributed to the annual value of $6.3 million for FY2017, which is 9527.01% down from last year.
  • Latest data reveals that Vertex Pharmaceuticals reported Non-Current Deferred Tax Liability of $9.4 million as of Q3 2018, which was down 1187.04% from $9.3 million recorded in Q2 2018.
  • In the past 5 years, Vertex Pharmaceuticals' Non-Current Deferred Tax Liability ranged from a high of $136.6 million in Q2 2017 and a low of $6.3 million during Q4 2017
  • In the last 5 years, Vertex Pharmaceuticals' Non-Current Deferred Tax Liability had a median value of $111.3 million in 2015 and averaged $74.8 million.
  • As far as peak fluctuations go, Vertex Pharmaceuticals' Non-Current Deferred Tax Liability soared by 64378.19% in 2016, and later tumbled by 9527.01% in 2017.
  • Over the past 5 years, Vertex Pharmaceuticals' Non-Current Deferred Tax Liability (Quarter) stood at $15.0 million in 2014, then soared by 634.11% to $110.4 million in 2015, then rose by 21.39% to $134.1 million in 2016, then plummeted by 95.27% to $6.3 million in 2017, then skyrocketed by 48.46% to $9.4 million in 2018.
  • Its Non-Current Deferred Tax Liability stands at $9.4 million for Q3 2018, versus $9.3 million for Q2 2018 and $9.6 million for Q1 2018.